Where are vaccines approved?
50 Vaccines Approved by at Least One Country
The vaccines listed below are those that have been approved, authorized, licensed, granted emergency use authorization, or made available for use outside of clinical trials via any pathway by a regulatory agency, a national authority, or another entity.
-
Anhui Zhifei Longcom
Zifivax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 4 countries
21 trials in 5 countries
-
Bagheiat-allah University of Medical Sciences
Noora vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
3 trials in 1 country
-
Bharat Biotech
Covaxin- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 14 countries
16 trials in 2 countries
-
Bharat Biotech
iNCOVACC- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
4 trials in 1 country
-
Biological E Limited
Corbevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
7 trials in 1 country
-
CanSino
Convidecia- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 10 countries
14 trials in 6 countries
-
CanSino
Convidecia Air- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
5 trials in 4 countries
-
Center for Genetic Engineering and Biotechnology (CIGB)
Abdala- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 6 countries
5 trials in 1 country
-
Chumakov Center
KoviVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 3 countries
5 trials in 1 country
-
Gamaleya
Gam-COVID-Vac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
2 trials in 0 countries
-
Gamaleya
Sputnik Light- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 26 countries
7 trials in 3 countries
-
Gamaleya
Sputnik V- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 74 countries
25 trials in 8 countries
-
Gennova Biopharmaceuticals Limited
GEMCOVAC-19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
2 trials in 1 country
-
Health Institutes of Turkey
Turkovac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
8 trials in 1 country
-
Instituto Finlay de Vacunas Cuba
Soberana 02- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 4 countries
7 trials in 2 countries
-
Instituto Finlay de Vacunas Cuba
Soberana Plus- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
5 trials in 1 country
-
Janssen (Johnson & Johnson)
Jcovden- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 113 countries
26 trials in 25 countries
-
Livzon Mabpharm Inc
V-01- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
7 trials in 3 countries
-
Medicago
Covifenz- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
6 trials in 6 countries
-
Medigen
MVC-COV1901- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 4 countries
15 trials in 4 countries
-
Moderna
Spikevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 88 countries
70 trials in 24 countries
-
Moderna
Spikevax Bivalent Original/Omicron BA.1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 38 countries
5 trials in 4 countries
-
Moderna
Spikevax Bivalent Original/Omicron BA.4/BA.5- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 33 countries
2 trials in 1 country
-
National Vaccine and Serum Institute
Recombinant SARS-CoV-2 Vaccine (CHO Cell)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
3 trials in 2 countries
-
Novavax
Nuvaxovid- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 40 countries
22 trials in 14 countries
-
Organization of Defensive Innovation and Research
FAKHRAVAC (MIVAC)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
3 trials in 1 country
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
73 trials in 34 countries
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
100 trials in 31 countries
-
Pfizer/BioNTech
Comirnaty Bivalent Original/Omicron BA.1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 35 countries
3 trials in 5 countries
-
Pfizer/BioNTech
Comirnaty Bivalent Original/Omicron BA.4/BA.5- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 33 countries
4 trials in 1 country
-
PT Bio Farma
IndoVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
4 trials in 1 country
-
Razi Vaccine and Serum Research Institute
Razi Cov Pars- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
5 trials in 1 country
-
Research Institute for Biological Safety Problems (RIBSP)
QazVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
3 trials in 1 country
-
Sanofi/GSK
VidPrevtyn Beta- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 30 countries
3 trials in 2 countries
-
Serum Institute of India
Covishield (Oxford/ AstraZeneca formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 49 countries
6 trials in 1 country
-
Serum Institute of India
COVOVAX (Novavax formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 6 countries
7 trials in 3 countries
-
Shenzhen Kangtai Biological Products Co
KCONVAC- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
7 trials in 1 country
-
Shifa Pharmed Industrial Co
COVIran Barekat- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
6 trials in 1 country
-
Sinopharm (Beijing)
Covilo- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 93 countries
39 trials in 18 countries
-
Sinopharm (Wuhan)
Inactivated (Vero Cells)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
9 trials in 7 countries
-
Sinovac
CoronaVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 56 countries
42 trials in 10 countries
-
SK Bioscience Co Ltd
SKYCovione- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
7 trials in 6 countries
-
Takeda
TAK-019 (Novavax formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
3 trials in 1 country
-
Takeda
TAK-919 (Moderna formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
2 trials in 1 country
-
Valneva
VLA2001- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 33 countries
9 trials in 4 countries
-
Vaxine/CinnaGen Co.
SpikoGen- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
8 trials in 2 countries
-
Vector State Research Center of Virology and Biotechnology
Aurora-CoV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
2 trials in 1 country
-
Vector State Research Center of Virology and Biotechnology
EpiVacCorona- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 4 countries
4 trials in 1 country
-
Walvax
AWcorna- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
4 trials in 3 countries
-
Zydus Cadila
ZyCoV-D- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
6 trials in 1 country